Keyphrases
Chicago
100%
Cancer Patients
100%
Malignancy
100%
Metropolitan Areas
100%
Hospital Systems
100%
Patients with COVID-19
100%
Old Age
50%
Patient Demographics
50%
Illinois
50%
Comorbidity
50%
Overall Survival
50%
Current Treatment
50%
Clinical Outcomes
50%
Hemoglobin
50%
Clinical Assessment
50%
Inflammatory Markers
50%
Male Gender
50%
Proactive Strategy
50%
Patients with Cancer
50%
Poor Clinical Outcomes
50%
Associated Complications
50%
Vulnerable Populations
50%
D-dimer
50%
Infected Patients
50%
Laboratory Assessment
50%
Ferritin
50%
Critical Illness
50%
Systemic Disease
50%
COVID-19
50%
SARS-CoV-2 Infection
50%
COVID-19 Risk
50%
Coronavirus Disease (COVID)
50%
COVID-19 Related
50%
Platelet Count
50%
Procalcitonin
50%
Antitumor Treatment
50%
Medicine and Dentistry
COVID-19
100%
Cancer
50%
Overall Survival
25%
Patient Population
25%
Platelet
25%
Infection
25%
Laboratory Assessment
25%
Vulnerable Population
25%
Ferritin
25%
Clinical Assessment
25%
Dimer
25%
Lactate Dehydrogenase
25%
Critical Illness
25%
Procalcitonin
25%
Severe Acute Respiratory Syndrome Coronavirus 2
25%
Medicine
25%
Cancer Treatment
25%
Systemic Disorder
25%
Immunotherapy
25%
Immunosuppressive Drug
25%
Comorbidity
25%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Overall Survival
33%
Infection
33%
Immunosuppressive Agent
33%
Ferritin
33%
Critical Illness
33%
Dimer
33%
SARS Coronavirus
33%
Procalcitonin
33%
Immunotherapy
33%
Neoplasm
33%
Lactate Dehydrogenase
33%
Comorbidity
33%
Diseases
33%
Immunology and Microbiology
COVID-19
100%
Immunosuppressive Drug
25%
Severe Acute Respiratory Syndrome Coronavirus 2
25%
Overall Survival
25%
Vulnerable Population
25%
Platelet Count
25%
Immunotherapy
25%
Procalcitonin
25%
Comorbidity
25%
Ferritin
25%
Hemoglobin
25%